Efficacy of neuromodulation on the treatment of fibromyalgia: A network meta-analysis

Gen Hosp Psychiatry. 2024 Mar-Apr:87:103-123. doi: 10.1016/j.genhosppsych.2024.01.007. Epub 2024 Jan 26.

Abstract

Objective: Several types of neuromodulation have been investigated for the treatment of fibromyalgia, but they show varied efficacy on pain, functioning, comorbid depression and comorbid anxiety. Whether some types of neuromodulation or some factors are associated with a better response also awaits clarification.

Methods: We conducted a systematic review and network meta-analysis of randomized controlled trials to evaluate the efficacy of neuromodulation in patients with fibromyalgia. We searched PubMed, EMBASE, the Cochrane Central Register of Controlled Trials and PsycINFO before March 2022. We employed a frequentist random-effects network meta-analysis.

Results: Forty trials involving 1541 participants were included. Compared with sham control interventions, several types of transcranial direct current stimulation (tDCS), transcranial random noise stimulation (tRNS), and high-frequency repetitive transcranial magnetic stimulation (rTMS) were associated with significant reduction of pain, depression, anxiety, and improvement in functioning. Many significantly effective treatment options involve stimulation of the primary motor cortex or dorsolateral prefrontal cortex.

Conclusion: We concluded that several types of rTMS, tDCS and tRNS may have the potential to be applied for clinical purposes.

Keywords: Fibromyalgia; Network meta-analysis; Neuromodulation; Repetitive transcranial magnetic stimulation; Transcranial direct current stimulation.

Publication types

  • Systematic Review
  • Meta-Analysis
  • Review

MeSH terms

  • Fibromyalgia* / therapy
  • Humans
  • Network Meta-Analysis
  • Pain
  • Transcranial Direct Current Stimulation*
  • Transcranial Magnetic Stimulation
  • Treatment Outcome